Abstract
Early detection and quantification of cardiac damage in cancer patients are essential to readily intervene with cardioprotective strategies and avoid the need of the discontinuation of antineoplastic treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have